Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Capital Reinvestment Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Capital Reinvestment Ratio of 1.33x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.19 Million) in capital expenditures (CN¥17.49 Million). See Tianjin Tianyao Pharmaceuticals Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2000–2024)
This chart tracks Tianjin Tianyao Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. For live market cap and broader valuation context, see Tianjin Tianyao Pharmaceuticals Co Ltd (600488) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥569.37 Million | CN¥77.74 Million | ▼ -19.7% |
| 2023 | 0.17x | CN¥783.01 Million | CN¥133.15 Million | ▼ -45.0% |
| 2022 | 0.31x | CN¥653.52 Million | CN¥202.20 Million | ▼ -73.6% |
| 2021 | 1.17x | CN¥316.89 Million | CN¥370.84 Million | ▼ -11.5% |
| 2020 | 1.32x | CN¥346.88 Million | CN¥458.51 Million | ▲ +32.3% |
| 2019 | 1.00x | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.1% |
| 2018 | 1.08x | CN¥189.27 Million | CN¥203.58 Million | ▲ +5.1% |
| 2016 | 1.02x | CN¥63.32 Million | CN¥64.78 Million | ▲ +192.3% |
| 2015 | 0.35x | CN¥129.50 Million | CN¥45.32 Million | ▲ +272.9% |
| 2014 | 0.09x | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥41.06 Million | CN¥36.29 Million | — |